October 2009
MonTueWedThuFriSatSun
« Sep Nov »
 1234
567891011
12131415161718
19202122232425
262728293031 

Month October 2009

S&P 500 (SPX) : Ichimoku Chart Reading as of Oct 27, 2009

The index has been falling for the past few days.

However, up till now, there is still NO CONFIRMATION of a BEARISH move.

On the Daily Chart, we can see that yesterday’s close is sitting on top of the Kijun sen at 1060

Further down, another support is at 1048 (or 1050).

On the Weekly Chart, it provides insight to the greater trend.

We can see that there is a huge kumo support below and the leading kumo is starting to twist; a suggestion that it is not in a STRONG bearish move. If however, SPX does goes below the kumo, then we have a STRONG BEARISH SIGNAL.

2009Oct-S&P 500-800x600

2009Oct-S&P 500-800x600_Weekly

PALM Inc. (PALM) : Strong Bearish Cross

PALM Ichimoku’s Chart just had a strong bearish signal.

Yesterday, it has a bearish cross with the Tenkan sen cutting the Kujun sen.

And today, the price has fallen below the kumo support on the Daily Chart.

Suggestion:

- SELL

PALM_Bearish

Sinovac Biotech Ltd (SVA) : Obtains Third H1N1 Vaccine Order From Chinese Central Government

From Reuters:

Sinovac Biotech Ltd. announced that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China’s Ministry of Industry and Information Technology for the national stockpiling plan.

Under this purchase order, Sinovac is required to produce an additional 5.19 million doses of PANFLU.1 (15ug/0.5ml) for the Chinese central government. Out of announced PANFLU.1 order, Sinovac is required to complete delivery of 2.89 million doses to the appointed provincial and municipal governments by the end of this year and supply the remaining 2.3 million doses for the central government stockpiling.

The latest 5.19 million dose purchase order is in addition to an initial order for 3.3 million doses and second order for 3 million doses received by Sinovac from the Ministry of Industry and Information Technology of China on September 4, 2009 and September 30, 2009, respectively, for a total of 11.49 million doses.